logo

Preparation and bio-distribution of bone tumor therapeutic agent 188Re-TCTMP

RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICINE

Preparation and bio-distribution of bone tumor therapeutic agent 188Re-TCTMP

JIANG Shu-bin
LUO Shun-zhong
DENG Hou-fu
BIN Wen-zeng
WANG Wen-jin
WEI Hong-yuan
LIU Guo-ping
Nuclear Science and TechniquesVol.15, No.1pp.39-42Published in print 01 Feb 2004
23800

TCTMP (1,4,8,11-tetraaza cyclotetradecyl-1,4,8,11-tetramethylene phosphonate) was synthesized and coupled with 188Re. The 188Re-TCTMP's coupling condition, stability and bio-distribution in mice were investigated. The results showed that satisfactory yield of 188Re could be obtained under the conditions of media pH=2.0, 0.8~1.6mg of SnCl2 and 50mg of ligand. 188Re-TCTMP was stable (complexation yield >95%) in 8d without protection of N2. The result of bio-distribution indicated that 188Re-TCTMP had a strong affinity to skeleton and very low non-target tissue's uptake, and the amount of 188Re-TCTMP in blood was (0.06±0.02)%ID/g 6h after injection, whereas the concentration of 188Re-HEDP (1-hydroxy-ethylidene diphosphonate) in blood was (0.28±0.05)%ID/g 6 h after injection. Compared with 188Re-HEDP, 188Re-TCTMP exhibits better potential for the treatment of metastases.

188ReTCTMPBone tumorBio-distribution
References
[1] Jiang S B, Luo S Z, Deng H F et al. J Nucl radiochem (in Chinese), 2002, 24: 105-108
[2] Neves M, Gano L, Pereira N et al. Nucl Med Biol, 2002, 29(3): 329-338
[3] Han S H, Klerk J M, Zonnenberg B A et al. Q J Nucl Med, 2001, 45(1): 84-90
[4] Chakraborty S, Das T, Unni P R et al. Nucl Med Commun, 2002, 23(1): 67-74
[5] Hassfjell S P, Bruland O S, Hoff P. Nucl Med Biol, 1997, 24(3): 231-237
[6] Murud K M, Larsen R H, Bruland O S et al. Nucl Med Biol, 1999, 26(7): 791-794
[7] He J H, Luo S Z, Yang Y Q et al. Nucl Sci Tech, 2002, 13: 105-109
[8] Murphy A C, Ferrpo F G, Pedraa L M et al. Appl Radiat Isot, 2001, 54(3): 435-442
[9] Oh S J, Won K S, Moon D H et al. Nucl Med Commun, 2002, 23(1): 75-81
[10] Chen F D, Hsieh B T, Wang H E et al. Nucl Med Biol, 2001, 28(7): 835-844
[11] Jung A, Bisaz S, Fleisch H. Calcif Tissue Res, 1973, 11: 269-280
[12] Geockler W F, Edwards B, Volkert W A et al. J Nucl Med, 1987, 28: 495-504
[13] Jurisson S, Berning D, Jia W et al. Chem Rev, 1993, 93: 1137-1156
[14] Uchtman V A. J Phys Chem, 1972, 76: 1304-1310
[15] Barnett B L, Strickland L C. Acta Crystallogr B, 1979, 35: 1212-1214
[16] Volkert W A, Deutsch E A. Advances in metals in medicine, JAI Press, 1993, 115-149
[17] Moedritzer K, Irani R. J Org Chem, 1966, 31: 1603-1607
[18] Kothari K, Pillal M R A, Unnip R et al. Appl Radia Isot, 1999, 51: 51-58
[19] Prakash S, Went M J and Blower P J. Nucl Med Biol, 1996, 23: 543-549